2afx: Difference between revisions

Revision as of 17:27, 21 February 2008

Crystal structure of human glutaminyl cyclase in complex with 1-benzylimidazole

OverviewOverview

N-terminal pyroglutamate (pGlu) formation from its glutaminyl (or glutamyl) precursor is required in the maturation of numerous bioactive peptides. The aberrant formation of pGlu may be related to several pathological processes, such as osteoporosis and amyloidotic diseases. This N-terminal cyclization reaction, once thought to proceed spontaneously, is greatly facilitated by the enzyme glutaminyl cyclase (QC). To probe this important but poorly understood modification, we present here the structure of human QC in free form and bound to a substrate and three imidazole-derived inhibitors. The structure reveals an alpha/beta scaffold akin to that of two-zinc exopeptidases but with several insertions and deletions, particularly in the active-site region. The relatively closed active site displays alternate conformations due to the different indole orientations of Trp-207, resulting in two substrate (glutamine t-butyl ester)-binding modes. The single zinc ion in the active site is coordinated to three conserved residues and one water molecule, which is replaced by an imidazole nitrogen upon binding of the inhibitors. Together with structural and kinetic analyses of several active-site-mutant enzymes, a catalysis mechanism of the formation of protein N-terminal pGlu is proposed. Our results provide a structural basis for the rational design of inhibitors against QC-associated disorders.

About this StructureAbout this Structure

2AFX is a Single protein structure of sequence from Homo sapiens with , and as ligands. Active as Glutaminyl-peptide cyclotransferase, with EC number 2.3.2.5 Full crystallographic information is available from OCA.

ReferenceReference

Crystal structures of human glutaminyl cyclase, an enzyme responsible for protein N-terminal pyroglutamate formation., Huang KF, Liu YL, Cheng WJ, Ko TP, Wang AH, Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13117-22. Epub 2005 Aug 31. PMID:16135565

Page seeded by OCA on Thu Feb 21 16:27:01 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2afx.gif|left|200px]]<br />
+[[Image:2afx.gif|left|200px]]<br /><applet load="2afx" size="350" color="white" frame="true" align="right" spinBox="true"
-<applet load="2afx" size="450" color="white" frame="true" align="right" spinBox="true"
 caption="2afx, resolution 1.64&Aring;" />
 '''Crystal structure of human glutaminyl cyclase in complex with 1-benzylimidazole'''<br />
 ==Overview==
-N-terminal pyroglutamate (pGlu) formation from its glutaminyl (or, glutamyl) precursor is required in the maturation of numerous bioactive, peptides. The aberrant formation of pGlu may be related to several, pathological processes, such as osteoporosis and amyloidotic diseases., This N-terminal cyclization reaction, once thought to proceed, spontaneously, is greatly facilitated by the enzyme glutaminyl cyclase, (QC). To probe this important but poorly understood modification, we, present here the structure of human QC in free form and bound to a, substrate and three imidazole-derived inhibitors. The structure reveals an, alpha/beta scaffold akin to that of two-zinc exopeptidases but with, several insertions and deletions, particularly in the active-site region., The relatively closed active site displays alternate conformations due to, the different indole orientations of Trp-207, resulting in two substrate, (glutamine t-butyl ester)-binding modes. The single zinc ion in the active, site is coordinated to three conserved residues and one water molecule, which is replaced by an imidazole nitrogen upon binding of the inhibitors., Together with structural and kinetic analyses of several, active-site-mutant enzymes, a catalysis mechanism of the formation of, protein N-terminal pGlu is proposed. Our results provide a structural, basis for the rational design of inhibitors against QC-associated, disorders.
+N-terminal pyroglutamate (pGlu) formation from its glutaminyl (or glutamyl) precursor is required in the maturation of numerous bioactive peptides. The aberrant formation of pGlu may be related to several pathological processes, such as osteoporosis and amyloidotic diseases. This N-terminal cyclization reaction, once thought to proceed spontaneously, is greatly facilitated by the enzyme glutaminyl cyclase (QC). To probe this important but poorly understood modification, we present here the structure of human QC in free form and bound to a substrate and three imidazole-derived inhibitors. The structure reveals an alpha/beta scaffold akin to that of two-zinc exopeptidases but with several insertions and deletions, particularly in the active-site region. The relatively closed active site displays alternate conformations due to the different indole orientations of Trp-207, resulting in two substrate (glutamine t-butyl ester)-binding modes. The single zinc ion in the active site is coordinated to three conserved residues and one water molecule, which is replaced by an imidazole nitrogen upon binding of the inhibitors. Together with structural and kinetic analyses of several active-site-mutant enzymes, a catalysis mechanism of the formation of protein N-terminal pGlu is proposed. Our results provide a structural basis for the rational design of inhibitors against QC-associated disorders.
 ==About this Structure==
-AFX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with ZN, SO4 and 1BN as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Glutaminyl-peptide_cyclotransferase Glutaminyl-peptide cyclotransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.2.5 2.3.2.5] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2AFX OCA].
+AFX is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=SO4:'>SO4</scene> and <scene name='pdbligand=1BN:'>1BN</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Glutaminyl-peptide_cyclotransferase Glutaminyl-peptide cyclotransferase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.3.2.5 2.3.2.5] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2AFX OCA].
 ==Reference==
@@ Line 15: / Line 14: @@
 [[Category: Homo sapiens]]
 [[Category: Single protein]]
-[[Category: Cheng, W.J.]]
+[[Category: Cheng, W J.]]
-[[Category: Huang, K.F.]]
+[[Category: Huang, K F.]]
-[[Category: Ko, T.P.]]
+[[Category: Ko, T P.]]
-[[Category: Liu, Y.L.]]
+[[Category: Liu, Y L.]]
-[[Category: Wang, A.H.J.]]
+[[Category: Wang, A H.J.]]
 [[Category: 1BN]]
 [[Category: SO4]]
@@ Line 26: / Line 25: @@
 [[Category: metalloprotein]]
-''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:50:42 2007''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:27:01 2008''